Why people switch from tirzepatide to semaglutide The decision to switch from tirzepatide to semaglutide typically stems from practical rather than medical reasons
Gutzwiller JP, Tschopp S, Bock A, Zehnder CE, Huber AR, Kreyenbuehl M, Gutmann H, Drewe J, Henzen C, Goeke B, et al: Glucagon-like peptide 1 induces natriuresis in healthy subjects and in insulin-resistant obese men
Waseem, M., Tabassum, H
Studies comparing medicationonly care to programs that combine GLP1 therapy with nutrition and behavioural support show better sustained weight loss, fewer side effects and less weight regain once the drug is stopped in the supported groups (Wilding et al., 2021)
Your body is encountering a new compound with a new receptor profile, and even though two of the three pathways are familiar, the experience is different
Dietary advanced glycation end products and their role in health and disease